In a recent announcement, the administration of Old Uncle Joe had stated that it has plans to push forward with a COVID_19 vaccination program aimed at young children, between the ages of 5-11 years old, if the regulators finally approve of vaccines to use on them in the upcoming weeks.
This new plan seems to rely on the fact that the regulators will approve the vaccines for use on the intended age group, a task that will be decided upon in the coming weeks and is most definitely not a sure thing. A meeting of independent advisory committees for the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) is slated to take place on the 25th of October and November 2-3, respectively, and these agency-wide changes could be seen in the wake of the meetings.
Recently, the White House has made it a point to brag about the efficacy of vaccines and their overall effectiveness in the prevention of severe COVID-19 and death for the large majority of circumstances. The administration has also gone on to state that they have managed to gather enough vaccines to allow for every child in the country between the ages of 5-11 to receive the necessary vaccinations.
“Millions of adolescents ages 12-17 have been safely vaccinated, and we know vaccines work,” stated the White House in a release this past Wednesday. “Fully vaccinated individuals are 10 times less likely to be hospitalized with COVID-19 and have a high degree of protection, including against the Delta variant. The consequences of a pediatric COVID-19 case can be serious and potentially last months.”
“As with vaccination for those 12 and older, the success of this program will rely heavily on states, Tribes, and territories to help implement a smooth rollout,” stated the administration additionally. “A major component of the Administration’s operational planning is working closely with state and local leaders to ensure they are prepared to distribute and administer vaccines.”
However, very few children have died as a result of COVID-19 complications when compared to adults across America and especially when compared to immunocompromised adults, such as seniors or people with underlying medical conditions.
Since way back in January of 2020, less than 450 children between the ages of 5 -18 have died as a result of COVID-19 complications, as reported by a set of provisional data from the Centers for Disease Control and Prevention (CDC). As stated by the American Academy of Pediatrics, across the 45 states that have current data as of the 18th of October, cases of childhood COVID-19 resulted in deaths at a rate of 0%-.03% in infected children.
“At this time, it appears that severe illness due to COVID-19 is uncommon among children,” stated the academy. “However, there is an urgent need to collect more data on longer-term impacts of the pandemic on children, including ways the virus may harm the long-term physical health of infected children, as well as its emotional and mental health effects.”
Old Uncle Joe’s administration has stated that they have taken multiple extra steps to ensure that the plan will go smoothly should the regulators approve of the shots.
“If authorized by the FDA and recommended by the CDC, the Pfizer-BioNTech vaccine for [5- to 11-year-olds] will be a dose and formula specifically for this age group,” stated the administration. “The vaccine will have packaging available in smaller configurations that will make it easier for physicians’ offices and other smaller, community-based providers to offer the vaccine to kids and their families.”